In contrast, various natural and synthetic compounds have been reported to shift Hb’s allosteric equilibrium towards a high-affinity state and have also been investigated as potential therapeutic agents for the treatment of sickle cell disease. This evidence concerns the gene GSTM1 and sickle cell disease.